ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 171 filers reported holding ASCENDIS PHARMA A/S in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $51 | +4.1% | 544 | 0.0% | 0.00% | – |
| Q2 2023 | $49 | -15.5% | 544 | 0.0% | 0.00% | – |
| Q1 2023 | $58 | -99.4% | 544 | +597.4% | 0.00% | – |
| Q1 2022 | $9,000 | -10.0% | 78 | 0.0% | 0.00% | – |
| Q4 2021 | $10,000 | -16.7% | 78 | 0.0% | 0.00% | – |
| Q3 2021 | $12,000 | +20.0% | 78 | 0.0% | 0.00% | – |
| Q2 2021 | $10,000 | 0.0% | 78 | 0.0% | 0.00% | – |
| Q1 2021 | $10,000 | – | 78 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 2,046,832 | $240,912,000 | 24.02% |
| RA Capital Management | 4,132,442 | $486,388,000 | 20.97% |
| VHCP Management II, LLC | 504,210 | $59,346,000 | 17.36% |
| Ghost Tree Capital, LLC | 385,000 | $45,315,000 | 11.84% |
| Sofinnova Investments, Inc. | 998,538 | $117,528,000 | 11.33% |
| Foresite Capital Management IV, LLC | 245,424 | $28,886,000 | 10.38% |
| Avoro Capital Advisors LLC | 1,795,000 | $211,272,000 | 9.14% |
| Orbimed Advisors | 3,970,673 | $467,348,000 | 7.24% |
| Eventide Asset Management | 1,698,648 | $199,931,000 | 6.88% |
| Foresite Capital Management III, LLC | 204,088 | $24,021,000 | 6.25% |